Acetyl-L-Carnitine and Nicotinamide for Prevention of Type 1Diabetes I-Literature Rewiew Which Gave Support to the Treatment. II-Case Report, Evaluation of Five Years Treatment | ||
| dc.conicet.organizacion | Gobierno de la Ciudad de Buenos Aires. Hospital General de Niños "Ricardo Gutierrez" | |
| dc.conicet.organizacion | Gobierno de la Ciudad de Buenos Aires. Hospital General de Niños "Ricardo Gutierrez" | |
| dc.conicet.organizacion | Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Parque Centenario. Centro de Investigaciones Endocrinológicas | |
| dc.conicet.organizacion | Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Parque Centenario. Centro de Investigaciones Endocrinológicas | |
| dc.conicet.organizacion | Fundación de las Enfermedades Neurometabólicas | |
| dc.conicet.organizacion | Fundación de las Enfermedades Neurometabólicas | |
| dc.conicet.organizacion | Universidad de Buenos Aires. Facultad de Medicina. Hospital de Clínicas General San Martín | |
| dc.conicet.organizacion | Universidad de Buenos Aires. Facultad de Medicina. Hospital de Clínicas General San Martín | |
| dc.conicet.organizacion | Gobierno de la Ciudad de Buenos Aires. Hospital General de Niños "Ricardo Gutierrez" | |
| dc.conicet.organizacion | Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Parque Centenario. Centro de Investigaciones Endocrinológicas | |
| dc.contributor.author | Fernandez, Ivana | |
| dc.contributor.author | Tonietti, Miriam | |
| dc.contributor.author | Camberos, Maria del Carmen | |
| dc.contributor.author | Bergada, Ignacio | |
| dc.contributor.author | Schenone, Andrea | |
| dc.contributor.author | Szlago, Marina | |
| dc.contributor.author | Tellechea, Mariana Lorena | |
| dc.contributor.author | Fretchtel, Gustavo | |
| dc.contributor.author | Trifone, Liliana | |
| dc.contributor.author | Cresto, Juan Carlos | |
| dc.date.issued | 2015-06 | |
| dc.description.abstract | n the first part, this article review the accepted knowledge of type 1 diabetes, its physiopathology, the importance of cytokines and the induction of apoptosis and necrosis during its evolution. Throughout this work we describe in more detail the inhibition of this mechanism of cell destruction by acetyl-L-carnitine and nicotinamide. We also explain the complementary action of their association which gave support to the treatment. In the second part, we present the complete evolution of 8 children treated with the oral medication of 50 mg/Kg of acetyl-L-carnitine plus 25 mg/Kg of nicotinamide during 5 years. We published the first 2 years of evolution under treatment in these children (JPEM 26: 347, 2013). The children had positive auto-antibodies and were consanguineous of type 1 diabetic patients. The intravenous glucose tolerance test (IVGTT) showed a first phase of insulin release minor of 48 μU to enter in the protocol, and the same test was used for children evolution. Seven out eight children stopped the treatment because they normalized the metabolic parameters and no one became diabetic. All children increased the insulin response to IVGTT (between 1.44 to 5.69 times). Along the treatment, seven of these eight children turned their positive auto-antibodies into negatives. | es |
| dc.description.fil | Fil: Fernandez, Ivana. Gobierno de la Ciudad de Buenos Aires. Hospital General de Niños "Ricardo Gutierrez"; Argentina | |
| dc.description.fil | Fil: Tonietti, Miriam. Gobierno de la Ciudad de Buenos Aires. Hospital General de Niños "Ricardo Gutierrez"; Argentina | |
| dc.description.fil | Fil: Camberos, Maria del Carmen. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Parque Centenario. Centro de Investigaciones Endocrinológicas; Argentina | |
| dc.description.fil | Fil: Bergada, Ignacio. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Parque Centenario. Centro de Investigaciones Endocrinológicas; Argentina | |
| dc.description.fil | Fil: Schenone, Andrea. Fundación de las Enfermedades Neurometabólicas; Argentina | |
| dc.description.fil | Fil: Szlago, Marina. Fundación de las Enfermedades Neurometabólicas; Argentina | |
| dc.description.fil | Fil: Tellechea, Mariana Lorena. Universidad de Buenos Aires. Facultad de Medicina. Hospital de Clínicas General San Martín; Argentina | |
| dc.description.fil | Fil: Fretchtel, Gustavo. Universidad de Buenos Aires. Facultad de Medicina. Hospital de Clínicas General San Martín; Argentina | |
| dc.description.fil | Fil: Trifone, Liliana. Gobierno de la Ciudad de Buenos Aires. Hospital General de Niños "Ricardo Gutierrez"; Argentina | |
| dc.description.fil | Fil: Cresto, Juan Carlos. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Parque Centenario. Centro de Investigaciones Endocrinológicas; Argentina | |
| dc.format | application/pdf | es |
| dc.identifier.citation | Fernandez, Ivana; Tonietti, Miriam; Camberos, Maria del Carmen; Bergada, Ignacio; Schenone, Andrea; et al.; Acetyl-L-Carnitine and Nicotinamide for Prevention of Type 1Diabetes I-Literature Rewiew Which Gave Support to the Treatment. II-Case Report, Evaluation of Five Years Treatment; Omics International; Immunome Research; 11; 2; 6-2015; 1000094-1000094 | es |
| dc.identifier.issn | 1745-7580 | |
| dc.identifier.uri | http://hdl.handle.net/11336/8185 | |
| dc.journal.number | 2 | es |
| dc.journal.pagination | 1000094-1000094 | es |
| dc.journal.pais | Estados Unidos | es |
| dc.journal.title | Immunome Research | es |
| dc.journal.volume | 11 | es |
| dc.language.iso | eng | es |
| dc.publisher | Omics International | es |
| dc.relation.alternativeid | info:eu-repo/semantics/altIdentifier/url/http://www.omicsonline.com/open-access/acetyllcarnitine-and-nicotinamide-for-prevention-of-type-1-diabetes-iliterature-review-which-gave-support-to-the-treatment-iicase-report-evaluation-of-five-years-treatment-1745-7580-1000094.php?aid=55708 | |
| dc.relation.alternativeid | info:eu-repo/semantics/altIdentifier/doi/http://dx.doi.org/10.4172/17457580.1000094 | |
| dc.rights | info:eu-repo/semantics/openAccess | * |
| dc.rights.uri | https://creativecommons.org/licenses/by/2.5/ar/ | es |
| dc.subject | Acetyl-L-Carnitine And Nicotinamide Treatment | es |
| dc.subject | Prevention of Type 1 Diabetes | es |
| dc.subject | Evaluation of Treatment | es |
| dc.subject.classification | Endocrinología y Metabolismo | es |
| dc.subject.classification | Medicina Clínica | es |
| dc.subject.classification | CIENCIAS MÉDICAS Y DE LA SALUD | es |
| dc.title | Acetyl-L-Carnitine and Nicotinamide for Prevention of Type 1Diabetes I-Literature Rewiew Which Gave Support to the Treatment. II-Case Report, Evaluation of Five Years Treatment | es |
| dc.type | info:eu-repo/semantics/article | |
| dc.type | info:ar-repo/semantics/artículo | |
| dc.type | info:eu-repo/semantics/publishedVersion | |
Archivos
Bloque original
Cargando...
- Nombre:
- CONICET_Digital_Nro.10732.pdf
- Tamaño:
- 2.18 MB
- Formato:
- Adobe Portable Document Format